Celldex Therapeutics
CLDX
#4622
Rank
S$2.77 B
Marketcap
S$35.37
Share price
-1.93%
Change (1 day)
8.57%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2026 (TTM): S-$5.60

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is S-$5.61. In 2025 the company made an earnings per share (EPS) of S-$5.02 a decrease over its 2024 EPS that were of S-$3.16.

EPS history for Celldex Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$5.6011.63%
2025S-$5.0258.78%
2024S-$3.16
2022S-$3.0845.73%
2021S-$2.12-23.36%
2020S-$2.76-41.05%
2019S-$4.68-76.95%
2018S-$20.32
2016S-$24.38-3.82%
2015S-$25.35-0.76%
2014S-$25.54
2012S-$19.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.92-116.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$22.42-499.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$3.71-166.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
S-$5.66 0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S-$5.17-7.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$2.61-146.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$6.50 15.86%๐Ÿ‡บ๐Ÿ‡ธ USA